RA Medical Systems Inc (NYSE:RMED) insider Dean Irwin sold 20,928 shares of the stock in a transaction on Thursday, April 11th. The shares were sold at an average price of $3.49, for a total transaction of $73,038.72. The transaction was disclosed in a filing with the SEC, which is available at this link.
RMED stock opened at $4.16 on Wednesday. The company has a market capitalization of $51.86 million and a P/E ratio of -1.25. The company has a quick ratio of 11.28, a current ratio of 11.64 and a debt-to-equity ratio of 0.01. RA Medical Systems Inc has a 52 week low of $3.34 and a 52 week high of $22.00.
RA Medical Systems (NYSE:RMED) last posted its quarterly earnings results on Thursday, March 14th. The company reported ($1.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.83). The business had revenue of $1.99 million for the quarter, compared to the consensus estimate of $2.92 million. As a group, equities research analysts forecast that RA Medical Systems Inc will post -1.93 EPS for the current fiscal year.
RMED has been the topic of a number of recent analyst reports. Zacks Investment Research cut shares of RA Medical Systems from a “hold” rating to a “sell” rating in a report on Saturday, April 20th. SunTrust Banks restated a “positive” rating and issued a $10.00 price target on shares of RA Medical Systems in a report on Tuesday, March 26th. Cantor Fitzgerald lowered their price target on shares of RA Medical Systems from $21.00 to $11.00 and set an “overweight” rating on the stock in a report on Monday, March 18th. Finally, Maxim Group lowered their target price on shares of RA Medical Systems to $15.00 and set a “buy” rating for the company in a research note on Friday, March 15th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. RA Medical Systems currently has an average rating of “Buy” and a consensus price target of $14.75.
WARNING: This news story was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/08/insider-selling-ra-medical-systems-inc-rmed-insider-sells-20928-shares-of-stock.html.
RA Medical Systems Company Profile
Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.
See Also: What is the balance sheet?
Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.